Ross S. Berkowitz

Active 1978–2025

120
Papers
19,284
Citations
83
h-index
116
i10-index

Citations

Citations per year for Ross S. Berkowitz1979: 1 citations1981: 2 citations1982: 2 citations1984: 7 citations1985: 6 citations1986: 18 citations1987: 14 citations1988: 13 citations1989: 14 citations1990: 14 citations1991: 12 citations1992: 18 citations1993: 26 citations1994: 20 citations1995: 30 citations1996: 31 citations1997: 25 citations1998: 29 citations1999: 35 citations2000: 50 citations2001: 69 citations2002: 81 citations2003: 87 citations2004: 106 citations2005: 127 citations2006: 92 citations2007: 87 citations2008: 121 citations2009: 123 citations2010: 133 citations2011: 122 citations2012: 121 citations2013: 118 citations2014: 122 citations2015: 140 citations2016: 120 citations2017: 132 citations2018: 106 citations2019: 430 citations2020: 464 citations2021: 424 citations2022: 315 citations2023: 214 citations2024: 323 citations2025: 152 citations2026: 3 citations1980: no citations, so this year is not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,789 citing papers, 32.2% of this breakdownChina: 535 citing papers, 9.6% of this breakdownUnited Kingdom: 419 citing papers, 7.6% of this breakdownCanada: 265 citing papers, 4.8% of this breakdownGermany: 211 citing papers, 3.8% of this breakdownItaly: 202 citing papers, 3.6% of this breakdownJapan: 178 citing papers, 3.2% of this breakdownAustralia: 172 citing papers, 3.1% of this breakdownNetherlands: 152 citing papers, 2.7% of this breakdownFrance: 143 citing papers, 2.6% of this breakdownSpain: 121 citing papers, 2.2% of this breakdownIndia: 105 citing papers, 1.9% of this breakdown
0%32.2%Other 22.7%

Fields

  • Medicine64%
  • Biochemistry, Genetics and Molecular Biology27.4%
  • Immunology and Microbiology3.2%
  • Chemistry1.5%
  • Engineering1.1%
  • Neuroscience0.9%
  • Other1.9%

Topics

  • Ovarian cancer diagnosis and treatment9.7%
  • Endometrial and Cervical Cancer Treatments3.5%
  • Gestational Trophoblastic Disease Studies3%
  • Cancer Cells and Metastasis2.5%
  • Cancer-related molecular mechanisms research2.3%
  • PARP inhibition in cancer therapy2.2%
  • Other76.8%

Coauthors

All papers

Open in search
  1. Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 457

  2. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2020 cited by 215

  3. A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1983 cited by 2,187

  4. Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship

    Authors: , , , , , , , , , , , , - The American Journal of Surgical Pathology 2007 cited by 1,113

  5. Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

    Authors: , , , , , , , , , , , , , , - Cell 2015 cited by 377

  6. Gestational trophoblastic disease

    Authors: , , - The Lancet 2010 cited by 1,026

  7. Diagnosis and Management of Gestational Trophoblastic Disease: 2021 Update

    Authors: , , , , , , , - International Journal of Gynecology & Obstetrics 2021 cited by 287

  8. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy

    Authors: , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 327

  9. Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer

    Authors: , , , , , , , , , , , - eLife 2017 cited by 146

  10. Update on the diagnosis and management of gestational trophoblastic disease

    Authors: , , , , , , , - International Journal of Gynecology & Obstetrics 2018 cited by 447

  11. Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis

    Authors: , , , - International Journal of Molecular Sciences 2013 cited by 174

  12. A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Cell 2009 cited by 261

  13. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study

    Authors: , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 cited by 66

  14. Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities

    Authors: , , - Gynecologic Oncology 2016 cited by 147

  15. Liquid biopsy of HPV DNA in cervical cancer

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Virology 2019 cited by 84

  16. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes.

    Authors: , , , , - Journal of Biological Chemistry 1988 cited by 514

  17. Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer

    Authors: , , , , , , , , , , , - Clinical Cancer Research 2008 cited by 132

  18. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome

    Authors: , , , , , , , , , , , , - International Journal of Gynecological Pathology 2016 cited by 93

  19. Update on the diagnosis and management of gestational trophoblastic disease

    Authors: , , , , , , - International Journal of Gynecology & Obstetrics 2015 cited by 363

  20. Current management of gestational trophoblastic diseases

    Authors: , - Gynecologic Oncology 2008 cited by 303

  21. Quality of life in long-term cervical cancer survivors

    Authors: , , , , , , , , - Gynecologic Oncology 2005 cited by 254

  22. SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer Cells

    Authors: , , , , , , - American Journal Of Pathology 2001 cited by 225

  23. Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer

    Authors: , , , , , , , , , - Psycho-Oncology 2007 cited by 215

  24. Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2012 cited by 162